Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

3.

Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup.

Capoor MR, Nair D, Srivastava L, Gupta B, Aggarwal P.

J Commun Dis. 2005 Jun;37(2):99-107.

PMID:
16749272
4.
5.

Molecular mechanisms associated with nosocomial carbapenem-resistant Acinetobacter baumannii in Mexico.

Alcántar-Curiel MD, García-Torres LF, González-Chávez MI, Morfín-Otero R, Gayosso-Vázquez C, Jarillo-Quijada MD, Fernández-Vázquez JL, Giono-Cerezo S, Rodríguez-Noriega E, Santos-Preciado JI.

Arch Med Res. 2014 Oct;45(7):553-60. doi: 10.1016/j.arcmed.2014.10.006. Epub 2014 Nov 1.

PMID:
25450581
6.

[In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates].

Nayman Alpat S, Aybey AD, Akşit F, Ozgüneş I, Kiremitçi A, Usluer G.

Mikrobiyol Bul. 2010 Oct;44(4):641-5. Turkish.

PMID:
21063976
7.

[Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].

Eser OK, Ergin A, Hasçelik G.

Mikrobiyol Bul. 2009 Jul;43(3):383-90. Turkish.

PMID:
19795613
8.

Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.

Mohanty S, Maurya V, Gaind R, Deb M.

J Infect Dev Ctries. 2013 Nov 15;7(11):880-7. doi: 10.3855/jidc.2924.

9.
10.
11.

[Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].

Zhao C, Xie W, Zhang W, Ye Z, Wu H.

Zhonghua Shao Shang Za Zhi. 2014 Apr;30(2):166-70. Chinese.

PMID:
24989663
12.

Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.

Park YK, Jung SI, Park KH, Kim SH, Ko KS.

Int J Antimicrob Agents. 2012 Jan;39(1):81-5. doi: 10.1016/j.ijantimicag.2011.08.006. Epub 2011 Oct 12.

PMID:
21996405
13.

Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection.

Vitkauskiene A, Dambrauskiene A, Cerniauskiene K, Rimdeika R, Sakalauskas R.

Scand J Infect Dis. 2013 Mar;45(3):213-8. doi: 10.3109/00365548.2012.724178. Epub 2012 Oct 31.

PMID:
23113773
14.

Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.

Park YK, Jung SI, Park KH, Kim DH, Choi JY, Kim SH, Ko KS.

J Med Microbiol. 2012 Jan;61(Pt 1):71-9. doi: 10.1099/jmm.0.033852-0. Epub 2011 Aug 18.

PMID:
21852525
15.

[Carbapenems resistance of Acinetobacter spp strains isolated from wound swabs during 2009-2010].

Medić D, Ukropina MM, Gusman V, Jelesić Z, Milosavljević B.

Med Pregl. 2011 Nov-Dec;64(11-12):583-7. Serbian.

PMID:
22369005
16.

[Distribution of blaOXA genes in Acinetobacter baumannii strains: a multicenter study].

Ciftci IH, Aşık G, Karakeçe E, Oksüz L, Yağcı S, Sesli Çetin E, Ozdemir M, Atasoy AR, Koçoğlu E, Gül M, Kurtoğlu MG, Köksal Çakırlar F, Seyrek A, Berktaş M, Gültepe B, Ayyildiz A.

Mikrobiyol Bul. 2013 Oct;47(4):592-602. Turkish.

17.

In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore.

Lim TP, Tan TY, Lee W, Sasikala S, Tan TT, Hsu LY, Kwa AL.

J Antibiot (Tokyo). 2009 Dec;62(12):675-9. doi: 10.1038/ja.2009.99. Epub 2009 Oct 30.

PMID:
19876075
18.

Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.

Nemec A, Krízová L, Maixnerová M, Diancourt L, van der Reijden TJ, Brisse S, van den Broek P, Dijkshoorn L.

J Antimicrob Chemother. 2008 Sep;62(3):484-9. doi: 10.1093/jac/dkn205. Epub 2008 May 13.

PMID:
18477708
19.

[Mechanisms of carbapenems resistance in acinetobacter and progress of treatment].

Zhang W, Liu KZ.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 Sep;39(5):542-7. Review. Chinese.

PMID:
20936732
20.

Supplemental Content

Support Center